Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
Lopinavir/ritonavir, an anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drug, may be associated with the development of liver injury. In this paper, we reported an elderly female patient with drug-induced liver injury secondary to lopinavir/ritonavir, which was evaluated for their...
Saved in:
Main Authors: | Yue Sun, Ran Wang, Cai'e Wang, Xiaodong Shao, Xiaojie Zheng, Hui Li, Yingkai Chi, Baocheng Deng, Yiling Li, Shenghao Jin, Xingshun Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1492002/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
by: Dóra Paróczai, et al.
Published: (2025-01-01) -
Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo
by: Liang Gongwen, et al.
Published: (2016-03-01) -
Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement
by: Ananda Kumar Chettupalli, et al.
Published: (2025-01-01) -
Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment
by: Mohamed G. Yassin, et al.
Published: (2025-01-01) -
Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)